AAAAAA

   
Results: 1-20 |
Results: 20

Authors: MAY TW RAMBECK B JURGES U BLANKENHORN V JURGENS U
Citation: Tw. May et al., COMPARISON OF TOTAL AND FREE PHENYTOIN SERUM CONCENTRATIONS MEASURED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND STANDARD TDX ASSAY - IMPLICATIONS FOR THE PREDICTION OF FREE PHENYTOIN SERUM CONCENTRATIONS, Therapeutic drug monitoring, 20(6), 1998, pp. 619-623

Authors: RAMBECK B KURLEMANN G STODIECK SRG MAY TW JURGENS U
Citation: B. Rambeck et al., CONCENTRATIONS OF LAMOTRIGINE IN A MOTHER ON LAMOTRIGINE TREATMENT AND HER NEWBORN CHILD, European Journal of Clinical Pharmacology, 51(6), 1997, pp. 481-484

Authors: SCHNABEL R RAMBECK B MAY T JURGENS U LAHL R FRITSCH W
Citation: R. Schnabel et al., LACK OF INFLUENCE OF HISTOPATHOLOGICAL CHANGES ON CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE CONCENTRATIONS IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS (VOL 141, PG 87, 1996), Journal of the neurological sciences, 147(2), 1997, pp. 223-224

Authors: JUERGENS UH MAY TW RAMBECK B
Citation: Uh. Juergens et al., SIMULTANEOUS HPLC DETERMINATION OF VIGABATRIN AND GABAPENTIN IN SERUMWITH AUTOMATED PRE-INJECTION DERIVATIZATION, Journal of liquid chromatography & related technologies, 19(9), 1996, pp. 1459-1471

Authors: SCHNABEL R RAMBECK B MAY T JURGENS U LAHL R
Citation: R. Schnabel et al., RELATIONSHIP BETWEEN ISCHEMIC DAMAGE AND CONCENTRATIONS OF PHENYTOIN AND PHENOBARBITAL IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS IN VEGETATIVE STATE AT DEATH, Epilepsy research, 25(3), 1996, pp. 231-241

Authors: RAMBECK B SPECHT U WOLF P
Citation: B. Rambeck et al., PHARMACOKINETIC INTERACTIONS OF THE NEW ANTIEPILEPTIC DRUGS, Clinical pharmacokinetics, 31(4), 1996, pp. 309-324

Authors: MAY TW RAMBECK B JURGENS U
Citation: Tw. May et al., SERUM CONCENTRATIONS OF LAMOTRIGINE IN EPILEPTIC PATIENTS - THE INFLUENCE OF DOSE AND COMEDICATION, Therapeutic drug monitoring, 18(5), 1996, pp. 523-531

Authors: SCHNABEL R RAMBECK B MAY TW JURGENS U LAHL R VILLAGRAN R
Citation: R. Schnabel et al., LACK OF EFFECT OF HISTOLOGICAL LESIONS ON THE PHENYTOIN AND PHENOBARBITAL CONCENTRATIONS IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS (VOL 133, PG 177, 1995), Journal of the neurological sciences, 144(1-2), 1996, pp. 231-232

Authors: SCHNABEL R RAMBECK B MAY T JURGENS U LAHL R FRITSCH W
Citation: R. Schnabel et al., LACK OF INFLUENCE OF HISTOPATHOLOGICAL CHANGES ON CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE CONCENTRATIONS IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS, Journal of the neurological sciences, 141(1-2), 1996, pp. 87-94

Authors: MAY TW RAMBECK B SALKEKELLERMANN A
Citation: Tw. May et al., FLUCTUATIONS OF 10-HYDROXY-CARBAZEPINE DURING THE DAY IN EPILEPTIC PATIENTS, Acta neurologica Scandinavica, 93(6), 1996, pp. 393-397

Authors: KELLERMANN K SODITT V RAMBECK B KLINGE O
Citation: K. Kellermann et al., FATAL HEPATOTOXICITY IN A CHILD TREATED WITH VIGABATRIN, Acta neurologica Scandinavica, 93(5), 1996, pp. 380-381

Authors: SCHNABEL R RAMBECK B MAY TW JURGENS U LAHL R VILLAGRAN R
Citation: R. Schnabel et al., LACK OF EFFECT OF HISTOLOGICAL LESIONS ON THE PHENYTOIN AND PHENOBARBITAL CONCENTRATIONS IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS, Journal of the neurological sciences, 133(1-2), 1995, pp. 177-182

Authors: BLANKENHORN V JURGES U MAY T RAMBECK B
Citation: V. Blankenhorn et al., DRUG-MONITORING OF ANTIEPILEPTIC DRUGS - COMPARISON OF 2 ANALYTICAL METHODS - HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND ENZYME-IMMUNOASSAY, Epilepsia, 36, 1995, pp. 157-157

Authors: RAMBECK B JURGENS U
Citation: B. Rambeck et U. Jurgens, INFLUENCE OF ANTIEPILEPTIC DRUGS ON LAMOTRIGINE CONCENTRATIONS, Epilepsia, 36, 1995, pp. 162-162

Authors: RAMBECK B MAY TW JURGENS U BLANKENHORN V JURGES U KORNMERKER E
Citation: B. Rambeck et al., COMPARISON OF PHENYTOIN AND CARBAMAZEPINE SERUM CONCENTRATIONS MEASURED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, THE STANDARD TDX ASSAY, THE ENZYME-MULTIPLIED IMMUNOASSAY TECHNIQUE, AND A NEW PATIENT-SIDE IMMUNOASSAY CARTRIDGE SYSTEM, Therapeutic drug monitoring, 16(6), 1994, pp. 608-612

Authors: MAY TW KORNMERKER E RAMBECK B BOENIGK HE
Citation: Tw. May et al., PHARMACOKINETICS OF SULTHIAME IN EPILEPTIC PATIENTS, Therapeutic drug monitoring, 16(3), 1994, pp. 251-257

Authors: SCHNABEL R RAMBECK B MAY TW JURGENS U LAHL R
Citation: R. Schnabel et al., CONCENTRATIONS OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE IN SERUM, BRAIN-TUMORS AND PARATUMOROUS CORTEX - A PROSPECTIVE-STUDY OF 37 NEUROSURGICALLY TREATED EPILEPTIC PATIENTS, European neurology, 34(4), 1994, pp. 213-220

Authors: SCHNABEL R RAMBECK B MAY T JURGENS U LAHL R
Citation: R. Schnabel et al., EFFICACY OF CARBAMAZEPINE WITH RESPECT TO DISTRIBUTION OF CARBAMAZEPINE AND ITS METABOLITE 10,11-EPOXIDE IN CEREBRAL-TUMORS AND PARATUMOROUS CORTEX, Acta neurologica Scandinavica, 90(2), 1994, pp. 133-134

Authors: RAMBECK B WOLF P
Citation: B. Rambeck et P. Wolf, LAMOTRIGINE CLINICAL PHARMACOKINETICS, Clinical pharmacokinetics, 25(6), 1993, pp. 433-443

Authors: SALKEKELLERMANN A BAIER H RAMBECK B BOENIGK HE WOLF P
Citation: A. Salkekellermann et al., ACUTE ENCEPHALOPATHY WITH VIGABATRIN, Lancet, 342(8864), 1993, pp. 185-185
Risultati: 1-20 |